Executive Order 13813
Executive Order 13813 is a directive issued by the President of the United States on October 12, 2017. This order, titled "Promoting Healthcare Choice and Competition Across the United States," was signed by President Donald Trump with the aim of reforming certain aspects of the healthcare system in the United States.
Background[edit | edit source]
The Affordable Care Act, also known as Obamacare, was signed into law by President Barack Obama in 2010. This law aimed to increase the quality and affordability of health insurance, lower the uninsured rate by expanding public and private insurance coverage, and reduce the costs of healthcare for individuals and the government. However, it faced criticism and calls for repeal from some quarters, including Donald Trump.
Provisions[edit | edit source]
Executive Order 13813 directs the Secretary of Labor to expand access to health coverage by allowing more employers to form health insurance associations. It also directs the Departments of the Treasury, Labor, and Health and Human Services to consider expanding coverage through low cost short-term limited duration insurance (STLDI).
The order also calls for an increase in competition, quality, and cost-effectiveness in the healthcare system. It aims to achieve this by promoting innovative healthcare delivery models, improving access to and the usability of health information, and enhancing the ability of consumers to choose healthcare that is best for them.
Impact[edit | edit source]
The impact of Executive Order 13813 is still being assessed. Some experts believe that it could lead to increased competition and lower costs in the healthcare market. However, others have expressed concerns that it could lead to higher premiums for sicker individuals and those with pre-existing conditions, as healthier individuals opt for cheaper, less comprehensive plans.
See also[edit | edit source]
- Healthcare in the United States
- Health insurance in the United States
- Patient Protection and Affordable Care Act
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD